R. Kyle Palmer

677 total citations
22 papers, 559 citations indexed

About

R. Kyle Palmer is a scholar working on Nutrition and Dietetics, Sensory Systems and Biomedical Engineering. According to data from OpenAlex, R. Kyle Palmer has authored 22 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nutrition and Dietetics, 11 papers in Sensory Systems and 8 papers in Biomedical Engineering. Recurrent topics in R. Kyle Palmer's work include Biochemical Analysis and Sensing Techniques (12 papers), Olfactory and Sensory Function Studies (10 papers) and Advanced Chemical Sensor Technologies (8 papers). R. Kyle Palmer is often cited by papers focused on Biochemical Analysis and Sensing Techniques (12 papers), Olfactory and Sensory Function Studies (10 papers) and Advanced Chemical Sensor Technologies (8 papers). R. Kyle Palmer collaborates with scholars based in United States and Australia. R. Kyle Palmer's co-authors include T. Kendall Harden, Robert A. Nicholas, Joel B. Schachter, José L. Boyer, Dennis Sprous, James H. Woods, Michael S. Lawless, Robert W. Bryant, Francis X. Brennan and F. Raymond Salemme and has published in prestigious journals such as PLoS ONE, Pharmacological Reviews and Journal of Neurochemistry.

In The Last Decade

R. Kyle Palmer

22 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Kyle Palmer United States 13 205 201 166 156 107 22 559
Rafael Brito Brazil 9 192 0.9× 213 1.1× 27 0.2× 76 0.5× 117 1.1× 11 565
Yevgen Yudin United States 18 380 1.9× 65 0.3× 140 0.8× 506 3.2× 282 2.6× 27 856
Magdalena Kotańska Poland 15 271 1.3× 36 0.2× 29 0.2× 27 0.2× 123 1.1× 70 654
Hussein N. Rubaiy United Kingdom 15 197 1.0× 22 0.1× 36 0.2× 210 1.3× 129 1.2× 20 459
Rafael Rivas‐Santisteban Spain 16 227 1.1× 80 0.4× 53 0.3× 21 0.1× 273 2.6× 39 737
Fiona S. Cusdin United Kingdom 7 293 1.4× 31 0.2× 144 0.9× 221 1.4× 147 1.4× 9 539
Mary E. Lancaster United States 10 413 2.0× 75 0.4× 25 0.2× 29 0.2× 106 1.0× 11 741
William C. Valinsky Canada 12 248 1.2× 15 0.1× 168 1.0× 83 0.5× 67 0.6× 16 523
Romina V. Sepúlveda Chile 11 325 1.6× 22 0.1× 38 0.2× 158 1.0× 155 1.4× 26 488
Jannis Meents Germany 12 177 0.9× 19 0.1× 23 0.1× 202 1.3× 140 1.3× 20 565

Countries citing papers authored by R. Kyle Palmer

Since Specialization
Citations

This map shows the geographic impact of R. Kyle Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kyle Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kyle Palmer more than expected).

Fields of papers citing papers by R. Kyle Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Kyle Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kyle Palmer. The network helps show where R. Kyle Palmer may publish in the future.

Co-authorship network of co-authors of R. Kyle Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of R. Kyle Palmer. A scholar is included among the top collaborators of R. Kyle Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Kyle Palmer. R. Kyle Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palmer, R. Kyle, et al.. (2024). Sodium-dependent glucose co-transport proteins (SGLTs) are not involved in human glucose taste detection. PLoS ONE. 19(11). e0313128–e0313128. 1 indexed citations
2.
Palmer, R. Kyle. (2022). Why Taste Is Pharmacology. Handbook of experimental pharmacology. 275. 1–31. 4 indexed citations
3.
Palmer, R. Kyle, et al.. (2021). Rapid Throughput Concentration-Response Analysis of Human Taste Discrimination. Journal of Pharmacology and Experimental Therapeutics. 377(1). 133–145. 6 indexed citations
4.
Palmer, R. Kyle. (2018). A Pharmacological Perspective on the Study of Taste. Pharmacological Reviews. 71(1). 20–48. 13 indexed citations
5.
Palmer, R. Kyle, et al.. (2014). Correction: A High Throughput In Vivo Assay for Taste Quality and Palatability. PLoS ONE. 9(1). 4 indexed citations
6.
Palmer, R. Kyle & Charles A. Lunn. (2013). TRP Channels as Targets for Therapeutic Intervention in Obesity: Focus on TRPV1 and TRPM5. Current Topics in Medicinal Chemistry. 13(3). 247–257. 15 indexed citations
7.
Palmer, R. Kyle, et al.. (2013). A High Throughput In Vivo Assay for Taste Quality and Palatability. PLoS ONE. 8(8). e72391–e72391. 13 indexed citations
8.
Palmer, R. Kyle, Karnail S. Atwal, Rok Cerne, et al.. (2010). Triphenylphosphine Oxide Is a Potent and Selective Inhibitor of the Transient Receptor Potential Melastatin-5 Ion Channel. Assay and Drug Development Technologies. 8(6). 703–713. 60 indexed citations
9.
Sprous, Dennis & R. Kyle Palmer. (2010). The T1R2/T1R3 Sweet Receptor and TRPM5 Ion Channel. Progress in molecular biology and translational science. 91. 151–208. 19 indexed citations
10.
Sprous, Dennis, et al.. (2010). QSAR in the Pharmaceutical Research Setting: QSAR Models for Broad, Large Problems. Current Topics in Medicinal Chemistry. 10(6). 619–637. 50 indexed citations
11.
Brennan, Francis X., et al.. (2009). Pharmacologic Antagonism of the Oral Aversive Taste-Directed Response to Capsaicin in a Mouse Brief Access Taste Aversion Assay. Journal of Pharmacology and Experimental Therapeutics. 332(2). 525–530. 12 indexed citations
12.
Brennan, Francis X., et al.. (2008). Quantitative assessment of TRPM5-dependent oral aversiveness of pharmaceuticals using a mouse brief-access taste aversion assay. Behavioural Pharmacology. 19(7). 673–682. 25 indexed citations
13.
Palmer, R. Kyle. (2007). The Pharmacology and Signaling of Bitter, Sweet, and Umami Taste Sensing. Molecular Interventions. 7(2). 87–98. 55 indexed citations
14.
Palmer, R. Kyle, José L. Boyer, Joel B. Schachter, Robert A. Nicholas, & T. Kendall Harden. (1998). Agonist Action of Adenosine Triphosphates at the Human P2Y1 Receptor. Molecular Pharmacology. 54(6). 1118–1123. 145 indexed citations
15.
Li, Qing, Melanie Olesky, R. Kyle Palmer, T. Kendall Harden, & Robert A. Nicholas. (1998). Evidence that the p2y3 Receptor Is the Avian Homologue of the Mammalian P2Y6 Receptor. Molecular Pharmacology. 54(3). 541–546. 36 indexed citations
16.
Palmer, R. Kyle, David I. Yule, Edward L. McEwen, John A. Williams, & Stephen K. Fisher. (1996). Intra- and intercellular calcium signaling in human neuroepithelioma cells. PubMed. 14(1-3). 169–174. 1 indexed citations
17.
Boyer, José L., Joel B. Schachter, R. Kyle Palmer, et al.. (1996). Avian and human homologues of the P2Y1 receptor: Pharmacological, signaling, and molecular properties. Drug Development Research. 39(3-4). 253–261. 18 indexed citations
18.
Palmer, R. Kyle, David I. Yule, Edward L. McEwen, John A. Williams, & Stephen K. Fisher. (1994). Agonist‐Specific Calcium Signaling and Phosphoinositide Hydrolysis in Human SK‐N‐MCIXC Neuroepithelioma Cells. Journal of Neurochemistry. 63(6). 2099–2107. 10 indexed citations
19.
Palmer, R. Kyle, et al.. (1993). Disparity Between Blood Pressure and PRA Inhibition After Administration of a Renin Inhibitor to Anesthetized Dogs: Methodological Considerations. Clinical and Experimental Hypertension. 15(4). 663–681. 2 indexed citations
20.
Palmer, R. Kyle, et al.. (1989). Drug-reinforced responding: rapid determination of dose-response functions. Drug and Alcohol Dependence. 24(2). 135–142. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026